Functional characterization of genes in Plasmodium parasites often relies on genetic 2 manipulations to disrupt or modify a gene-of-interest. However, these approaches are limited by 3 the time required to generate transgenic parasites for P. falciparum and the availability of a 4 single drug selectable marker for P. yoelii. In both cases, there remains a risk of disrupting native 5 gene regulatory elements with the introduction of exogenous sequences. To address these 6 limitations, we have developed CRISPR-RGR, a SpCas9-based gene editing system for 7 Plasmodium that utilizes a Ribozyme-Guide-Ribozyme (RGR) sgRNA expression strategy. 8
tools have been developed to more efficiently interrogate the Plasmodium genome than is 7 To streamline CRISPR/SpCas9 editing in Plasmodium yoelii parasites, we developed a flexible, 133 single-plasmid construct that contains all necessary CRISPR/SpCas9 gene editing elements (Fig. 134 1, 1 st Generation). Expression of SpCas9::GFP, HsDHFR (to provide resistance to anti-folate 135 drugs), and sgRNAs were generated by individual iterations of the strong, constitutive pbef1α 136 promoter and the pbdhfr 3'UTR/terminator. Each of these cassettes is flanked by unique 137 restriction enzyme sites for easy modification and substitutions. In addition to these cassettes, we 138 incorporated a homology-directed repair (HDR) template to enable homology directed repair of 139 the double-strand breaks (DSBs) that are created by SpCas9. Because the sequence conservation 140 of these gene control elements between P. yoelii and P. berghei is exceptionally high, and that in 141 fact a mixture of elements from both species are used in the plasmids describe here, we 142 anticipate that gene editing using these plasmids will be possible in P. berghei as well.
144
The major differences between this CRISPR-based editing system for Plasmodium and those 145 previously described lie in the expression of the sgRNAs and the preparation of the sgRNA 146 and HDR template sequences. Existing Plasmodium CRISPR systems use RNA Polymerase 147 III-driven U6 promoters or T7 RNA Polymerase-based systems for sgRNA expression (11, 148 12). In contrast, we have expressed a transcript encoding a Ribozyme-Guide-Ribozyme (RGR) 149 unit that uses a minimal Hammerhead Ribozyme and a Hepatitis Delta Virus ribozyme to flank 150 the sgRNA on its 5' and 3' ends, respectively ( Fig. 1, inset) . This RGR approach, first 151 described in yeast (27) and since used in Leishmania (28) and zebrafish (29) , generates 152 sgRNAs with precisely defined 5' and 3' ends, and allows for the simultaneous expression of 153 multiple guides under control of a single promoter, including RNAP II promoters. While 154 RNAP II promoters are far more abundant than RNAP III promoters, they are not typically 155 8 used for sgRNA expression as their transcripts can initiate from multiple transcriptional start 156 sites (TSS's) and are capped and polyadenylated. The potential impact of these 5' extensions 157 and modifications upon sgRNA activity are not sufficiently understood to confidently use 158 them for this application. However, the inclusion of autocatalytic, self-cleaving ribozymes 159 within an RNA eliminates these potential problems with RNAP II transcripts, and their 160 beneficial properties of stage-specific and tunable expression levels can be used. Moreover, 161 these individual RGR units can be polymerized into an RGR array on a single transcript and be 162 used to generate multiple sgRNAs. In addition, our sgRNA design contains an extended 163 duplex and a single base change compared to the original sgRNA sequence, which has been 164 shown to have increase editing efficiency (30) . Finally, we leverage advances in synthetic 165 biology to create custom DNA fragments that can include the RGR transcript, short HDR 166 templates, or both, which greatly expedites plasmid generation. We anticipate that as the cost 167 of gene synthesis continues to decrease, these approaches can be scaled for use in both forward 168 and reverse genetic screens. A step-by-step tutorial for construct generation is provided in In order to functionally test this single-plasmid, CRISPR-RGR system, we targeted the gene 173 encoding the PyALBA4 RNA-binding protein, which we have previously characterized (10) .
174
Using conventional reverse genetics approaches, we have shown that pyalba4 can be deleted in 175 asexual blood stage parasites, which results in the production of 2-3 fold more mature male 176 gametocytes that can exflagellate as compared to wild-type parasites. Additionally, a C-terminal 177 GFP tag can be introduced with no observable effect upon parasite growth or transmission. In 178 9 order to delete pyalba4 by CRISPR-RGR, two sgRNA targets were chosen at the 5' and 3' ends 179 of its coding sequence by manually scanning for NGG PAM motifs and subsequent 180 computational assessment using the Eukaryotic Pathogen CRISPR guide RNA/DNA design tool 181 (http://grna.ctegd.uga.edu) ( Fig. 2A , red vertical lines). This tool provides a score for each 182 sgRNA based on the target specificity within the genome, as well the GC content and position-183 specific nucleotide composition for bases that have been shown to affect sgRNA efficiency.
184
Additionally, this tool will flag any sgRNA with long poly-T tracts (more than four in a row) 185 which can cause early termination of RNAP III transcripts. Because the RGR system utilizes 186 RNAP II promoters, we are not limited by sgRNAs containing poly-T tracts that are prevalent in 187 Plasmodium genomes (31) . The initial HDR template was designed with homology arms 188 comprised of ~800bp of sequence homologous to the target gene on either side of the two DSBs, 189 with a unique 18bp DNA barcode between them that could be used for unambiguous, simple 190 genotyping PCR. Notably, this barcode is not necessary for genome editing and could be omitted (2). We observed that a large subset of these parasites showed expression of SpCas9::GFP by 197 live fluorescence microscopy (data not shown), and genotyping PCR analysis showed efficient 198 editing of the pyalba4 locus ( Fig. 2A bottom) . Furthermore, by enriching for SpCas9::GFP-199 positive schizonts via Fluorescence-activated Cell Sorting (FACS), only edited parasites were 200 present by genotyping PCR. Thus, this CRISPR-RGR approach rapidly produced a transgenic 201 parasite population with no observable wild-type parasites present using as few as two mice.
203
We further verified that this population of CRISPR-generated pyalba4parasites had the same 204 phenotype as pyalba4transgenic parasites generated by conventional reverse genetic Because CRISPR-RGR rapidly and efficiently produced transgenic parasites when providing 211 large homology arms in the HDR template, we tested the effect that lengthening (~1000bp each 212 arm) and shortening (~80-100bp, ~250bp each arm) the homology arms had upon gene editing. 213 We observed that all homology arm lengths allowed for efficient gene editing, and that the 214 smallest HDR tested (80-100bp each arm) had the most efficient editing (as evidenced by the 215 least intense PCR amplicons for wild-type parasites) and could be selected in the same amount of 216 time as was required for the longer HDR templates (Fig. 2C ). Importantly, HDR arms of this 217 length, even with the skewed A-T content of P. yoelii's genome, can be chemically synthesized. 218 It is notable that over the course of these experiments, we observed that recombination was 219 occurring in E. coli between two instances of the pbef1α promoter, and that the RGR portion of 220 the plasmid was being excised. To stabilize the plasmid, we constructed a second generation of 221 editing plasmids with no repeated elements and have not observed spurious recombination events 222 11 occurring with this new design ( Fig. 1 2 nd Generation, Supp. Fig. 1 ). This second generation 223 design includes a single iteration of the pbef1α promoter and pyef1α 3'UTR to control expression 224 of HsDHFR, the pydhfr promoter and pbdhfr 3'UTR to control expression of SpCas9::GFP, and 225 either the pybip promoter or pygapdh promoter with the pybip 3'UTR to control transcription of 226 the RGR element. Using the same sgRNA targets and the 191bp HDR template, we found that 227 both promoters driving RGR expression edited parasites efficiently (Supp. Fig. 1 ). Furthermore, 228 we again verified with FACS and genotyping PCR that parasites expressing SpCas9::GFP only 229 contained the edited pyalba4 locus. Together these results show that single-plasmid CRISPR-
230
RGR is able to efficiently and robustly create gene deletions in P. yoelii parasites. transgenic parasites created by conventional methods (Fig. 3C ).
242
In contrast to conventional reverse genetic techniques, CRISPR/SpCas9 gene editing can be 243 accomplished without leaving a drug selectable marker in the edited locus. This enables multiple, 244 sequential gene edits to be made after curing the delivery plasmid, which is particularly useful 245 with rodent-infectious malaria parasites where only one drug selectable marker (DHFR) is 246 available. However, previous work has shown that completely curing these plasmids is 247 challenging, as resistant parasites can be recovered more than 50 days post-removal of drug 248 pressure (18) . To circumvent this issue, methods have been developed to negatively select 249 against parasites that retained the delivery plasmid following genome modification (18) . We 250 similarly attempted to cure the plasmid from FACS-selected PyALBA4::GFP parasites produced 251 using one sgRNA, and observed that the parasites remained drug resistant after more than 14 252 days following removal of drug pressure. An expanded genotyping PCR assay that interrogates 253 for both plasmid integration and locus replacement showed that both editing outcomes occurred 254 ( Fig. 3B ). 255 We reasoned that introduction of two DSBs, and thus two genome repair events, would ensure 256 that only locus replacement events would result. To test this, we selected a second sgRNA target 257 in the pyalba4 3' UTR downstream of the original sgRNA target, and introduced a second shield 258 mutation into the HDR template ( Fig. 3A ). Transfection of this plasmid, coupled with constant 259 selection with pyrimethamine, produced PyALBA4::GFP-expressing parasites. As before, 260 genotyping PCR showed that a significant fraction of the parasite population had been modified.
261
Notably, this two sgRNA design yielded only the desired locus replacement events and showed 262 no evidence of plasmid integration (Fig. 3B, right) . Furthermore, upon removal of drug pressure, 263 the parasites quickly (<1 week) became sensitive to pyrimethamine once more and were 264 amenable to subsequent transfections. 
279
For this approach, we constructed a CRISPRi plasmid similar to our 1 st generation CRISPR 280 plasmid but without an HDR template, which is unnecessary for this application (Fig. 1 ). This 281 plasmid encodes a nuclease dead dSpCas9::1xHA endonuclease (D10A, H840A), which permits 282 the detection of GFP tags fused to a protein-of-interest to detect changes in gene expression. To 283 test our CRISPRi plasmid, we utilized the marker-less PyALBA4::GFP transgenic parasite line, 284 which was enriched by FACS to remove wild-type parasites and cloned by limiting dilution.
285
Upon curing the CRISPR-RGR plasmid, these parasites regained pyrimethamine sensitivity, thus 286 permitting introduction of another plasmid. We chose this parasite line as 1) the fusion of GFP to 287 the C-terminus of PyALBA4 has no effect upon parasite growth and transmission, 2) is reporter expression cassette that have not performed well in predicting gene regulation effects 291 upon endogenous genes in other systems.
292
Using RNA-seq data to estimate the 5' UTR of the PyALBA4 locus ( Fig. 4A, Supp. Fig. 3 ), we 293 selected eleven individual sgRNA targets between the start of the contiguous RNA-seq reads 294 (approximately -800) and the ATG. We selected sgRNAs that will target either the template or 295 non-template strands of DNA to assess if strand-specific effects occur in Plasmodium, and that 296 target DNA at various distances away from the ATG to assess positional effects (Fig. 4A ). The falciparum ApiAP2 family, we found that the core motif of AP2-G (PF3D7_1222600), GTAC, is 319 present in the seed sequence and PAM site of these two sgRNAs although the functional 320 significance of this remains to be seen (36) . We did not observe any significant strand-dependent 321 effects (average of 1.99-fold knock down for 4 template strand targets, average of 2.08-fold 322 knock down for non-template strand targets). Finally, due to the presence of many auto-323 fluorescent events that could not be robustly gated out, we anticipate that we are underreporting Here we present CRISPR-RGR, a ribozyme-based CRISPR system for Plasmodium yoelii that 332 allows rapid and efficient gene editing in rodent-infectious parasites. This approach is powerful 333 and provides advantages over current methods. First, the production of multiple sgRNAs from a 334 single transcript greatly reduces the potential size of plasmids required for CRISPR-based gene 335 editing by using a single promoter and terminator for sgRNA expression. Importantly, these 336 sgRNAs can be designed to target a single gene in multiple locations as used here, but can be 337 extended to target multiple genes. The utility of using multiple sgRNAs for a single gene is 338 evident from the data presented here: the use of one sgRNA can result in a mixture of gene 339 editing outcomes (plasmid integration and locus replacement), whereas the use of two sgRNAs 340 produced only the desired locus replacement result. We strongly suggest that two or more 341 sgRNAs be used for CRISPR-based gene editing where locus replacement is the desired outcome 342 to eliminate the need for negative selection. Second, CRISPR-RGR can be programmed using 343 synthetically produced DNA fragments that can encode the RGR, HDR, or both elements, which 344 can be inserted in one or two molecular cloning steps. With the anticipated decreases in cost and 345 increases in capacity to synthesize large DNA fragments, this approach will streamline reagent 346 preparation and enable CRISPR screens at scale. Lastly, the FACS-based selection of transgenic 347 parasites expressing SpCas9::GFP or a protein-of-interest fused to GFP reduces the number of 348 mice required to produce transgenic parasite lines free from observable wild-type parasites.
349
Because it is still possible that wild-type parasites remain in the population at levels lower than 350 the limit of detection of PCR, caution is urged when phenotyping these parasites and it is our 351 opinion that these parasites should be cloned prior to these studies. minimum number of mice. Importantly, for subsequent genome modifications to be done, it is 360 essential for these parasites to regain drug sensitivity so that another plasmid can be introduced. Based upon these findings, there are several improvements that can be made to improve 380 CRISPR-based gene editing and regulation, some of which can be addressed using CRISPR- 381 18 RGR. First, the transfection efficiency of all Plasmodium species is woefully low (e.g. 0.01 to 382 0.05%) compared to other eukaryotes (often >70%), even with the use of Amaxa nucleofectors 383 (37) . However, it is notable that these efficiencies are typically determined by the number of 384 parasites receiving a plasmid and expressing some marker from it (e.g. GFP), and thus reflects analysis of a large number of sgRNAs that they have used in P. falciparum, and identified 399 parameters that correlate with higher specificities and on-target efficiencies (39) . An alternative 400 approach would be to use multiple sgRNAs for each gene editing attempt, which can be achieved 401 by CRISPR-RGR and appropriately designed HDR templates. Lastly, a similar strategy of using 402 multiple sgRNAs can be applied to CRISPRi to avoid the preliminary assessment of the best 403 placement of dSpCas9 in the gene control region. Coupled with effective trans-activation or 404 trans-repression domains, or epigenetic regulators, we hypothesize that substantial regulatory 405 effects can be achieved using CRISPR-RGR.
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Acknowledgements 407 We would like to thank Manuel Llinás and the members of the Lindner and Llinás labs, as well 408 as Istvan Albert, Brian Dawson, and Howard Salis for critical discussions and technical 409 assistance for this work. We also would like to thank our animal caretakers, and the Penn State Table 1 ). An empty cassette consisting of the pbef1α promoter and pbdhfr3'UTR were 439 synthesized (GeneWiz) and cloned into the HsDHFR+Cas9::GFP and HsDHFR+dCas9 plasmids 440 and used for expression of synthetic hammerhead Ribozyme-Guide-Hepatitis Delta Virus 441 Ribozyme (RGR) transcripts. RGR coding sequences were synthesized (GeneWiz, sgRNA target 442 sequences provided in Supp Table 3 ) based on the "optimized" sgRNA structure described in Table 2 ). These products were inserted into and sequenced in 460 pCR-Blunt, and then subcloned into pSL1165 to create pSL1166 (using the pybip promoter) and 461 pSL1211 (using the pygapdh promoter). These plasmids were transfected into Plasmodium yoelii 462 17XNL strain parasites and were analyzed for their editing efficiency. The empty vector and 463 pyalba4-targeted plasmids described in this work will be available on Addgene. Table   469 1). Table 1 : Oligonucleotide sequences used in this study. 590 These sequences include primers used to amplify the CRISPR plasmid elements, such as the 591 SpCas9, promoter sequences, and the HDR templates used, as well as those used for genotyping 592 PCR of the transgenic parasites that were generated. Total RNA-seq (Py17XNL)
